124 related articles for article (PubMed ID: 12503392)
1. In vitro antifungal activity of 3-phenyl-2H-benzoxazine-2,4(3H)-diones.
Waisser K; Kubicová L; Buchta V; Kubanová P; Bajerová K; Jirásková L; Bednarík O; Bures O; Holý P
Folia Microbiol (Praha); 2002; 47(5):488-92. PubMed ID: 12503392
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Palát K; Kaustová J; Danse HM; Möllmann U
Pharmazie; 2003 Feb; 58(2):83-94. PubMed ID: 12641321
[TBL] [Abstract][Full Text] [Related]
3. Relationships between the chemical structure of antimycobacterial substances and their activity against atypical strains. Part 14: 3-Aryl-6,8-dihalogeno-2H-1,3-benzoxazine-2,4(3H)-diones.
Waisser K; Hladuvková J; Gregor J; Rada T; Kubicová L; Klimesová V; Kaustová J
Arch Pharm (Weinheim); 1998 Jan; 331(1):3-6. PubMed ID: 9507695
[TBL] [Abstract][Full Text] [Related]
4. New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 6-chloro-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-dithiones.
Waisser K; Gregor J; Kubicová L; Klimesová V; Kunes J; Machácek M; Kaustová J
Eur J Med Chem; 2000; 35(7-8):733-41. PubMed ID: 10960190
[TBL] [Abstract][Full Text] [Related]
5. Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
Waisser K; Gregor J; Dostál H; Kunes J; Kubicová L; Klimesová V; Kaustová J
Farmaco; 2001 Oct; 56(10):803-7. PubMed ID: 11718275
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial and antifungal isosters of salicylamides.
Waisser K; Pesina M; Holý P; Pour M; Bures O; Kunes J; Klimesová V; Buchta V; Kubanová P; Kaustová J
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):322-35. PubMed ID: 12953220
[TBL] [Abstract][Full Text] [Related]
8. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
[TBL] [Abstract][Full Text] [Related]
9. Anti-Candida albicans properties of novel benzoxazine analogues.
Fringuelli R; Pietrella D; Schiaffella F; Guarraci A; Perito S; Bistoni F; Vecchiarelli A
Bioorg Med Chem; 2002 Jun; 10(6):1681-6. PubMed ID: 11937326
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vitro antifungal activity of N-benzylsalicylamide derivatives.
Kubanová P; Buchta V; Perina M; Waisser K; Pour M
Folia Microbiol (Praha); 2003; 48(3):346-50. PubMed ID: 12879744
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of antifungal evaluation of 2H-[1,2,3]Triazolo[4,5-g]isoquinoline-4,9-diones.
Ryu CK; Oh SY; Choi SJ; Kang DY
Chem Pharm Bull (Tokyo); 2014; 62(11):1119-24. PubMed ID: 25196129
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activity of 2-(4-substituted phenyl)-3(2H)-isothiazolones.
Adibpour N; Khalaj A; Rezaee S; Daneshtalab M
Folia Microbiol (Praha); 2007; 52(6):573-6. PubMed ID: 18450218
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-antifungal activity relationships of 3-aryl-5-alkyl-2,5-dihydrofuran-2-ones and their carbanalogues: further refinement of tentative pharmacophore group.
Pour M; Spulák M; Balsánek V; Kunes J; Kubanová P; Buchta V
Bioorg Med Chem; 2003 Jul; 11(13):2843-66. PubMed ID: 12788357
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Activity of New 2-Thioxo-benzo[g]quinazolin-4(3H)-one Derivatives.
Al-Salahi R; Abuelizz HA; Dib RE; Marzouk M; Alshammari MB
Med Chem; 2016; 13(1):85-92. PubMed ID: 27306606
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activity of some traditional Persian medicinal plants on pathogenic fungi.
Asgarpanah J; Hashemi SJ; Hashemi E; Askari K
Chin J Integr Med; 2017 Jun; 23(6):433-437. PubMed ID: 26129901
[TBL] [Abstract][Full Text] [Related]
16. Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.
Herreros E; Martinez CM; Almela MJ; Marriott MS; De Las Heras FG; Gargallo-Viola D
Antimicrob Agents Chemother; 1998 Nov; 42(11):2863-9. PubMed ID: 9797217
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of anthraquinone derivatives from Rheum emodi.
Agarwal SK; Singh SS; Verma S; Kumar S
J Ethnopharmacol; 2000 Sep; 72(1-2):43-6. PubMed ID: 10967452
[TBL] [Abstract][Full Text] [Related]
18. 3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring.
Pour M; Spulák M; Balsánek V; Kunes J; Buchta V; Waisser K
Bioorg Med Chem Lett; 2000 Aug; 10(16):1893-5. PubMed ID: 10969993
[TBL] [Abstract][Full Text] [Related]
19. Antifungal effects of hydrolysable tannins and related compounds on dermatophytes, mould fungi and yeasts.
Latté KP; Kolodziej H
Z Naturforsch C J Biosci; 2000; 55(5-6):467-72. PubMed ID: 10928561
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Sun QY; Xu JM; Cao YB; Zhang WN; Wu QY; Zhang DZ; Zhang J; Zhao HQ; Jiang YY
Eur J Med Chem; 2007 Sep; 42(9):1226-33. PubMed ID: 17335940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
